Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 338,000 | 276,000 | 325,000 | 1,925,000 | 1,947,000 |
| Receivables | 1,871,000 | 1,917,000 | 1,866,000 | 1,778,000 | 1,669,000 |
| Inventories | 1,788,000 | 1,752,000 | 1,736,000 | 1,610,000 | 1,603,000 |
| Other current assets | 885,000 | 874,000 | 889,000 | 799,000 | 793,000 |
| TOTAL | $5,144,000 | $5,083,000 | $5,065,000 | $6,317,000 | $6,229,000 |
| Non-Current Assets | |||||
| PPE Net | 2,273,000 | 2,246,000 | 2,265,000 | 2,252,000 | 2,109,000 |
| Intangibles | 18,910,000 | 19,232,000 | 19,530,000 | 18,109,000 | 18,047,000 |
| Other Non-Current Assets | 5,620,000 | 5,628,000 | 5,477,000 | 5,552,000 | 5,493,000 |
| TOTAL | $26,803,000 | $27,106,000 | $27,272,000 | $25,913,000 | $25,649,000 |
| Total Assets | $31,947,000 | $32,189,000 | $32,337,000 | $32,229,000 | $31,877,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 20,000 | 170,000 | 238,000 | 261,000 | 261,000 |
| Accounts payable and accrued liabilities | 803,000 | 732,000 | 696,000 | 794,000 | 674,000 |
| Accrued Expenses | 1,974,000 | 2,197,000 | 2,306,000 | 2,436,000 | 2,418,000 |
| Other current liabilities | 752,000 | 784,000 | 1,034,000 | 783,000 | 669,000 |
| TOTAL | $3,549,000 | $3,883,000 | $4,275,000 | $4,274,000 | $4,022,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,564,000 | 8,802,000 | 9,067,000 | 8,804,000 | 8,824,000 |
| Other Non-Current Liabilities | 1,916,000 | 1,988,000 | 2,000,000 | 2,220,000 | 2,296,000 |
| TOTAL | $10,758,000 | $11,055,000 | $11,328,000 | $11,334,000 | $11,394,000 |
| Total Liabilities | $14,307,000 | $14,938,000 | $15,603,000 | $15,607,000 | $15,416,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,432,311 | 1,431,614 | 1,429,571 | 1,426,725 | 1,424,993 |
| Common Shares | 17,000 | 17,000 | 17,000 | 17,000 | 17,000 |
| Retained earnings | -876,000 | -1,050,000 | -1,296,000 | -1,392,000 | -1,473,000 |
| Other shareholders' equity | 531,000 | 432,000 | 222,000 | 262,000 | 239,000 |
| TOTAL | $17,640,000 | $17,251,000 | $16,735,000 | $16,622,000 | $16,462,000 |
| Total Liabilities And Equity | $31,947,000 | $32,189,000 | $32,338,000 | $32,229,000 | $31,878,000 |